Home > Healthcare > Medical Devices > Diagnostic Devices > Preventive Healthcare Technologies and Services Market

Preventive Healthcare Technologies and Services Market Trends

Report ID: GMI7106
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Preventive Healthcare Technologies and Services Market Trends

The demand for preventive healthcare technologies and services has increased owing to growing awareness among individuals about the benefits of preventive healthcare and the importance of regular health check-ups. Preventive care can be more cost-effective eventually, making it an attractive option for both healthcare providers and payers. Thus, contributing towards the market progress.

Additionally, telehealth and remote patient monitoring technologies have gained prominence, allowing patients to access healthcare services and monitoring them from the comfort of their homes. This reduces the need for in-person visits and can enhance preventive healthcare efforts.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Preventive healthcare technologies and services industry size was USD 251.2 billion in 2023 and is estimated to reach USD 605.3 billion by 2032 owing to the growing prevalence of chronic diseases, such as diabetes and obesity.

The hospitals end-use segment held over 41% of the preventive healthcare technologies and services industry share in 2022 propelled by the strong presence of skilled healthcare professionals.

U.S. preventive healthcare technologies and services industry size was USD 70.9 billion in 2022 and is predicted to witness substantial growth through 2032 owing to rising technological advancements and substantial healthcare expenditure.

GlaxoSmithKline, Omnicell, Inc, Myriad Genetics, Omron Healthcare, Abbott Laboratories, Medtronic, Quest Diagnostics, Merck & Co. Inc., Sanofi, NOVX Systems Corp and Moderna, Inc. are some of the key preventive healthcare technologies and service providers.